New Delhi, April 8 Zydus Lifesciences Ltd announced on Wednesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, indicated for controlling blood sugar in adults with type 2 diabetes mellitus.The approval from the US Food and...
ahmedabad
blood sugar control
dapagliflozin
diabetes mellitus
generic drugs
pharmaceuticals
tabletformulation
type 2 diabetes
united states
usfda
zydus lifesciences